| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |